INO: Message Board for Inovio Biomedical Corporation - InvestorVillage

Inovio Biomedical Corporation

  INO website

INO   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 1865 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
1911 INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease Recurrent Respiratory Papillomatosis (RRP) GN billmax 1 11/23/2020 8:42:01 AM
1910 Re: Question about Phase 2 GN billmax 0 11/20/2020 2:10:49 PM
1909 Question about Phase 2 GN Dodger_Blue 0 11/19/2020 1:16:25 PM
1908 Inovio GN billmax 0 11/19/2020 12:24:50 PM
1907 Re: Device is ok for phase 2 but not phase 3. Donít quite understand. Eom GN co3aii 0 11/18/2020 1:04:23 PM
1906 Device is ok for phase 2 but not phase 3. Donít quite understand. Eom GN Dodger_Blue 0 11/18/2020 10:21:13 AM
1905 Re: INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense GN co3aii 0 11/18/2020 9:27:40 AM
1904 Re: INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense GN ibm gear slinger 0 11/17/2020 3:44:19 PM
1903 Re: INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense GN co3aii 0 11/16/2020 12:09:06 PM
1902 Re: INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense GN Dodger_Blue 0 11/16/2020 11:11:36 AM
Previous 1865 Messages Top of Message List
Go to Msg #  






Financial Market Data provided by
.
Loading...